tirzepatide higher dose trial for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled Frontiers | Efficacy and safety

Why Sacramento Chooses Zepbound for Lasting Weight Loss The journey to a healthier weight can feel like a lonely, uphill battle

Comparative long-term drug survival of Vedolizumab, Adalimumab, and Infliximab in biologic-Nave patients with ulcerative Colitis

Full article: European Atherosclerosis Society Kausik Ray MD FMedSci To view or add a comment, sign in New Insights from CLEAR Outcomes on Bempedoic Acid and Gout A recent post hoc analysis of the CLEAR Outcomes trial provides important clinical insights into the relationship between bempedoic acid, uric acid levels, and gout incidence

The HCMV specific inhibitor WAY-174865 (WAY) is marked in orange

But as usage has exploded by 587% since 2019, so have the lawsuits